TENX

NASDAQ · Biotechnology

Tenax Therapeutics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.87

+0.04 (+2.19%)

As of Aug 14, 3:16 PM ET ·

TENX News1 articles

Tenax Therapeutics Plunges 85% as Phase 3 Trial Misses Key Goals

Tenax Therapeutics (TENX) shares plummeted 85% premarket after its Phase 3 LEVEL trial failed to meet primary endpoints, erasing $425 million in market cap.